Cannabinoid Receptor 1 and 2 Signaling Pathways Involved in Sepsis
- 22 February 2021
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 56 (5), 673-681
- https://doi.org/10.1097/shk.0000000000001763
Abstract
Sepsis is defined as life-threatening organ dysfunction, caused by a dysregulated host response to an infection and can progress to septic shock, which represents a major challenge in critical care with a high mortality rate. Currently, there is no definitive treatment available for the dysregulated immune response in sepsis. Therefore, a better understanding of the pathophysiological mechanisms may be useful for elucidating the molecular basis of sepsis and may contribute to the development of new therapeutic strategies. The endocannabinoid system (ECS) is an emerging research topic for the modulation of the host immune response under various pathological conditions. Cannabinoid receptors include the cannabinoid type 1 receptor (CB1) and the cannabinoid type 2 receptor (CB2). This review addresses the main functionality of CB1 and CB2 in sepsis, which can contribute to a better understanding about the pathophysiology of sepsis. Specifically, we discuss the role of CB1 in the cardiovascular system which is one of the biological systems that are strongly affected by sepsis and septic shock. We are also reviewing the role of CB2 in sepsis, specially CB2 activation, which exerts anti-inflammatory activities with potential benefit in sepsis.Keywords
This publication has 96 references indexed in Scilit:
- Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in MiceMediators of Inflammation, 2013
- The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptorsThe Journal of Physiology, 2011
- Early potassium channel blockade improves sepsis‐induced organ damage and cardiovascular dysfunctionBritish Journal of Pharmacology, 2011
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1and CB2Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2010
- Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injuryFree Radical Biology & Medicine, 2010
- The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisIntensive Care Medicine, 2010
- Endogenous cannabinoids induce fever through the activation of CB1 receptorsBritish Journal of Pharmacology, 2009
- Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?Trends in Pharmacological Sciences, 2008
- CB2 receptors in the brain: role in central immune functionBritish Journal of Pharmacology, 2008
- Initial sequencing and comparative analysis of the mouse genomeNature, 2002